What a dose of ozone actually is
A dose is not a number. Concentration, volume, route and frequency are four different dimensions, and quoting one of them says about as much as saying a car was driven at speed.
Conversations about ozone therapy nearly always arrive at a number. Someone was treated “at thirty”, or read that “seventy is too strong”. Both statements say very little, and not because the numbers are wrong. They are like saying “the car was driven at speed”: one dimension of something that has four.
By the end of this piece you will know what a dose of ozone is made of, what each route of delivery is for, and how careful practice keeps the treatment safe.
Why is one number never a dose?
A number like thirty is a concentration: micrograms of ozone per millilitre of gas. It says how strong the gas is, and nothing else.
Multiply concentration by volume and you get the total ozone delivered. That total can differ several-fold between two treatments quoting the identical concentration. The route changes what the gas meets. The frequency decides whether the body is asked to adapt, or asked again before it has finished adapting. A dose is a product of four things, concentration, volume, route and frequency, and a single number quoted without the other three describes nothing at all.
What is in the syringe is never pure ozone. It is a mixture of oxygen and ozone, with ozone a small percentage of the whole. It is made on the spot, by passing medical grade oxygen through an electrical discharge. Ordinary air cannot be used, because its nitrogen would produce unwanted nitrogen gases. Medical ozone is always an oxygen-ozone mixture made at the point of use, and it cannot be bottled, stored or bought ready-made. The gas decays back to ordinary oxygen within minutes to hours.
So the gas is much the same everywhere. Where it is put is not.
What are the four routes, and what is each one for?
Four routes cover most careful practice, and they are not interchangeable. Each answers a different question.
The first is the blood route, called major autohaemotherapy. A small volume of blood is drawn into a sealed vessel, mixed gently with a matched volume of the gas, and returned through the same line. What flows back carries reaction products, not free gas. Concentration sits at the lower end, because red blood cells set a real ceiling on what is useful.
The second is rectal insufflation, where the gas is introduced into the rectum. The lining there absorbs it into the circulation, so this route gives a body-wide effect without a needle. It uses larger volumes at modest strength, and it is the practical choice where repeated drips are not sensible.
The third is local injection: small volumes into one joint, one disc, or one tissue plane. Here the aim is local, and the concentration is set by what that tissue tolerates.
The fourth is topical, treating a surface. A limb wound can be sealed inside a bag with the gas flowing through and safely extracted, at the upper end of the strength range, because the exposure is contained. Ozonated oil is the one shelf product. There the ozone has already reacted with the oil’s fats, and what stays in the bottle is the reaction products.
Which route uses the strongest gas? Most people guess the blood route, since a body-wide effect surely needs more. It is the other way round. The contained, surface-facing applications sit highest, and the routes that meet circulating blood sit lowest. The route decides whether the challenge is body-wide or local, and a concentration that suits one route can be wrong by ten-fold for another.
The actual figures, and how they are matched to a person, belong with trained practitioners working within a protocol. Which brings us to the parts of practice that never vary.
Which routes are never used?
Two delivery facts sit outside the adjustable dose entirely.
The first: medical ozone is never inhaled. The lining of the airways carries only a thin protective layer compared with blood, and ozone reacts with the first surface it touches. Every route is therefore designed so the gas never reaches the airway, and clinics run closed systems with extraction as standard equipment.
The second: the gas is never pushed directly into a vein. A bubble of any gas in a vein can block circulation, a mechanical event called an embolism. The phrase “intravenous ozone” is loose shorthand for the blood route above, where liquid blood is returned and free gas is not. These two are fixed delivery facts of the therapy: ozone is never inhaled, and the gas is never injected directly into a vein.
One question remains, and it is about the person, not the gas.
Why does screening ask about reserve?
Ozone works as a small, measured challenge that the body answers with its own protective response. A measured challenge only works if there is something to answer it with. That one idea explains the screening list better than memorising it.
The clearest example is a rare inherited enzyme shortage called G6PD deficiency. That enzyme keeps red blood cells stocked with the chemical power to recharge their own antioxidant defences. Without it, an oxidative load could break cells rather than train them. So practitioners screen for it before blood routes. Unstable acute illness follows the same logic: the body’s reserve is committed elsewhere. Pregnancy is set aside because the therapy has not been studied there. Screening exists because a measured challenge assumes reserve, and the screening list is simply the set of states where that reserve cannot be assumed.
The useful question about any ozone account is not “what concentration” but five questions together: what concentration, how much, by which route, how often, and screened for what. A practitioner who answers all five is describing a treatment properly.
Proven: ozone injection for pain from a slipped disc in the lower back, supported by randomised trials and pooled analyses. Promising: injection into the knee for osteoarthritis, where early trials lean positive. Being studied: most other uses, where researchers are still building the trial base. On safety, published clinical series report uncommon and usually minor events, most often brief discomfort at the treatment site. Those series come from trained, screened settings, which is exactly the point: dose discipline and screening are what the safety record rests on. Regulation differs between countries, so practice runs within each country’s framework.
Two ideas hold the subject together. Ozone works as an adjunct beside established care. And everything about it turns on concentration, volume, route, frequency and reserve, which is what makes it a clinical tool in trained hands.
- A dose is concentration times volume, by a route, at a frequency. One number says nothing.
- Medical ozone is made at the point of use from medical grade oxygen. It cannot be stored.
- Body-wide routes run gentler; local and surface routes run stronger, because the exposure is contained.
- The gas is never inhaled and never injected directly into a vein. Those are delivery facts.
- Screening maps onto one idea: a measured challenge assumes reserve.
Knowing what a dose is made of lets you read any ozone account clearly. The knowledge check is where that reading is tested.
Deep DiveOzone in practice: dose, route, and the screening that comes firstHow a course of ozone is actually reasoned about: the arithmetic that makes two protocols comparable, why the interval between sessions is part of the dose, the screening that has to come first, and how to recognise unsafe practice from outside the room.